GHRP-2 vs. ipamorelin for bulking: what the science says

What's this video probably claiming?

Based on the caption, @aubs.tattered appears to be documenting a personal experiment comparing multiple plates of food intake (likely a high-calorie eating protocol) alongside peptide use, specifically GHRP-2, a growth hormone releasing peptide. The creator seems to be suggesting they discovered a personal preference or better subjective response to GHRP-2 compared to another peptide, possibly ipamorelin or CJC-1295, in the context of a bulking phase. The hashtags confirm this is peptide-assisted mass-gaining content. The casual framing, 'fun experiment tho,' signals this is self-experimentation with no clinical oversight, no bloodwork mentioned, and no baseline controls. That matters because GHRP-2 and similar secretagogues produce measurably different hormonal profiles, and collapsing that into vibes-based personal response reporting is exactly how misinformation about peptide stacking spreads on platforms like TikTok to an audience of 11,000 viewers who may interpret anecdote as protocol.

What does the science actually show?

GHRP-2 (pralmorelin) is a synthetic hexapeptide that acts on the ghrelin receptor, stimulating pulsatile growth hormone release and, critically, also stimulating appetite and gastric motility through ghrelin pathway activation. Frieboes et al. (1995, Journal of Psychiatric Research) demonstrated GH pulse amplitudes roughly 2-3x above baseline with IV GHRP-2 administration in healthy men. Bowers et al. (1998, Journal of Endocrinology) showed GHRP-2 produces higher peak GH responses than GHRP-6 but with notable cortisol and prolactin co-secretion, effects largely absent from ipamorelin. Johansen et al. (2008, Drug Testing and Analysis) flagged GHRP-2 as a WADA-banned substance detectable in urine for up to 24 hours. The appetite-stimulating side effect the creator may be interpreting as a 'better response' is actually a pharmacological artifact of ghrelin receptor agonism, not a superior anabolic signal. Human clinical trials on GHRP-2 for body composition specifically are limited, small, and largely industry-funded.

Where does the social media noise diverge from clinical reality?

The framing of 'I respond better to X' implies a meaningful, measurable physiological difference. In reality, without serum IGF-1 testing, GH pulse monitoring, or DEXA scans taken at controlled intervals, what the creator is measuring is subjective, likely appetite differences, water retention, or mood shifts tied to cortisol and prolactin fluctuations that GHRP-2 is known to trigger. Raun et al. (1998, European Journal of Endocrinology) specifically compared ipamorelin to GHRP-2 and GHRP-6 in animal models, finding ipamorelin produced cleaner GH release with significantly less cortisol and ACTH stimulation. That is not a minor detail. Chronic cortisol elevation from repeated GHRP-2 use has real consequences for muscle protein synthesis, sleep architecture, and insulin sensitivity. Presenting this comparison as a casual food-and-peptide experiment to a bulking audience strips out the hormonal complexity entirely and normalizes unmonitored peptide stacking in a way that is genuinely concerning from a public health standpoint.

What should you actually know?

GHRP-2 is not approved by the FDA for any indication in the United States. Its use outside clinical research settings is off-label at best, and compounded versions available through some telehealth channels are not equivalent to research-grade pharmaceutical standards. If you are considering a growth hormone secretagogue for body composition, the comparison that actually matters is not which one makes you hungrier or feel different after three plates of food. It is which agent produces the most favorable GH-to-cortisol ratio, what the dosing frequency implications are for pituitary desensitization, and whether your IGF-1 levels are being monitored at baseline and follow-up. Giustina and Veldhuis (1998, Endocrine Reviews) outlined the pulsatility requirements for physiological GH signaling that most bro-science peptide protocols completely ignore. Before taking self-experimentation content at face value, ask whether the creator has any lab data to share. Spoiler: they almost never do.